US Stock MarketDetailed Quotes

SHANGHAI FOSUN PHARMACEUTICAL GROUP (SFOSF)

Watchlist
  • 2.200
  • 0.0000.00%
15min DelayClose Aug 19 14:49 ET
5.87BMarket Cap11.28P/E (TTM)

SHANGHAI FOSUN PHARMACEUTICAL GROUP (SFOSF) Income Statement

Quarterly·All
YOY yoy
Hide blank lines yoy
Currency: CNY
2026/Q1
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
2023/Q3
2023/Q2
2023/Q1
2022/Q4
2022/Q3
2022/Q2
2022/Q1
2021/Q4
2021/Q3
2021/Q2
Total Revenue as Reported
+6.93%10.07B
+20.81%12.27B
-5.46%9.88B
-2.05%10.09B
-7.26%9.42B
-5.09%10.16B
+12.30%10.45B
-2.08%10.31B
-6.56%10.16B
-13.22%10.70B
-9.44%9.30B
-4.00%10.52B
+4.68%10.87B
+3.06%12.33B
+1.78%10.28B
+23.23%10.96B
+28.91%10.38B
+45.81%11.96B
+25.03%10.10B
+9.19%8.90B
Total Operating Revenue
+6.93%10.07B
+20.81%12.27B
-5.46%9.88B
-2.05%10.09B
-7.26%9.42B
-5.09%10.16B
+12.30%10.45B
-2.08%10.31B
-6.56%10.16B
-13.22%10.70B
-9.44%9.30B
-4.00%10.52B
+4.68%10.87B
+3.06%12.33B
+1.78%10.28B
+23.23%10.96B
+28.91%10.38B
+45.81%11.96B
+25.03%10.10B
+9.19%8.90B
Cost of Revenue
+2.98%5.07B
+1.80%5.57B
-5.98%5.10B
-3.39%5.20B
-3.10%4.92B
-5.84%5.48B
+6.79%5.43B
-0.33%5.39B
-4.10%5.08B
-7.05%5.82B
-4.75%5.08B
-5.47%5.40B
-9.67%5.29B
-5.10%6.26B
-0.85%5.33B
+30.74%5.72B
+50.91%5.86B
+65.71%6.59B
+52.03%5.38B
+22.22%4.37B
Gross Profit
+11.25%5.01B
+43.05%6.69B
-4.90%4.78B
-0.59%4.89B
-11.41%4.50B
-4.18%4.68B
+18.91%5.02B
-3.92%4.92B
-8.90%5.08B
-19.57%4.88B
-14.51%4.22B
-2.40%5.12B
+23.28%5.58B
+13.08%6.07B
+4.77%4.94B
+15.97%5.25B
+8.42%4.52B
+27.08%5.37B
+3.97%4.72B
-1.01%4.52B
Operating Expense
+8.98%4.19B
+37.38%5.69B
-2.33%4.06B
+0.19%4.13B
-5.90%3.84B
-13.70%4.14B
-2.53%4.16B
-12.36%4.12B
-8.85%4.08B
-8.48%4.80B
+0.05%4.26B
+18.41%4.70B
+21.97%4.48B
+7.95%5.24B
+6.61%4.26B
+4.06%3.97B
+7.88%3.67B
+32.49%4.85B
+7.51%4.00B
+5.15%3.81B
Selling and Admin Expenses
+5.58%3.27B
+22.31%-2.54B
-4.59%6.29B
+45.37%-55.54M
-4.43%3.10B
-7.97%-3.26B
+0.45%6.60B
-131.48%-101.66M
-7.52%3.24B
-49.59%-3.02B
+7.88%6.57B
+81.67%322.99M
+22.60%3.51B
-44.60%-2.02B
+18.13%6.09B
-80.33%177.79M
+3.89%2.86B
-130.48%-1.40B
+68.08%5.15B
-24.10%903.87M
-Selling & Marketing Expense
+6.06%2.25B
+59.02%-505.32M
-6.15%3.72B
+9.16%420.81M
-5.11%2.13B
-19.88%-1.23B
+0.86%3.97B
-50.50%385.49M
-10.93%2.24B
-169.73%-1.03B
+2.74%3.93B
+29.69%778.74M
+21.59%2.52B
-5379.23%-381.37M
+16.60%3.83B
-49.80%600.49M
-0.51%2.07B
-98.40%7.22M
+39.64%3.28B
-16.08%1.20B
-General & Admin Expense
+4.53%1.02B
+0.02%-2.03B
-2.24%2.57B
+2.22%-476.35M
-2.91%973.13M
-1.83%-2.03B
-0.16%2.63B
-6.89%-487.15M
+1.13%1.00B
-21.64%-1.99B
+16.59%2.63B
-7.82%-455.76M
+25.25%991.09M
-16.71%-1.64B
+20.83%2.26B
-44.63%-422.70M
+17.46%791.31M
-32.79%-1.40B
+161.67%1.87B
-24.69%-292.27M
Research & Development
+21.61%896.79M
+28.78%1.28B
+28.81%1.01B
-5.13%979.21M
-11.10%737.45M
-16.34%996.32M
-22.97%786.30M
-11.43%1.03B
-14.38%829.57M
-17.26%1.19B
-1.42%1.02B
+14.54%1.17B
+19.66%968.87M
+1.12%1.44B
+21.56%1.04B
+10.46%1.02B
+26.35%809.68M
+55.10%1.42B
+26.53%851.90M
+29.40%921.05M
Other Operating Expenses
-22.63%74.61M
+29.24%103.67M
-19.26%56.20M
+23.04%88.32M
+4.31%96.43M
+9.44%80.21M
+15.26%69.61M
+1.74%71.78M
+37.93%92.44M
+16.31%73.29M
+49.27%60.39M
-0.47%70.55M
+25.41%67.02M
-15.53%63.01M
-80.09%40.46M
+181.91%70.89M
-4.82%53.44M
+130.59%74.60M
+229.51%203.23M
-261.14%-86.55M
Operating Profit
+24.53%818.84M
+86.44%1.01B
-17.19%717.39M
-4.59%763.28M
-34.00%657.55M
+517.02%540.61M
+2247.23%866.29M
+90.54%799.99M
-9.12%996.26M
-89.46%87.62M
-105.94%-40.34M
-67.11%419.85M
+28.94%1.10B
+61.38%831.28M
-5.49%678.81M
+79.98%1.28B
+10.82%850.16M
-8.22%515.11M
-12.12%718.22M
-24.74%709.28M
Net Non-Operating Interest Income (Expense)
+19.79%-222.34M
+51.26%-118.24M
-15.63%-367.07M
+7.05%-238.78M
+1.08%-277.18M
-0.55%-242.60M
-2.88%-317.45M
-37.92%-256.90M
-7.26%-280.22M
+27.04%-241.27M
-593.57%-308.55M
+18.14%-186.27M
-144.12%-261.26M
-46.83%-330.69M
+35.09%-44.49M
-15.84%-227.56M
+16.70%-107.02M
-6.05%-225.23M
+65.50%-68.53M
+12.07%-196.45M
Non-Operating Interest Income
-5.60%72.14M
-31.86%63.71M
-19.18%73.34M
-2.53%87.03M
-23.33%76.42M
-4.62%93.50M
-3.59%90.74M
+9.74%89.29M
+10.60%99.67M
+16.14%98.03M
+17.93%94.12M
+27.93%81.37M
+64.43%90.12M
+42.53%84.41M
+37.84%79.81M
+8.56%63.60M
-5.53%54.81M
+15.63%59.22M
+11.44%57.90M
+25.35%58.59M
Non-Operating Interest Expense
-10.02%296.51M
-19.97%291.32M
-10.35%321.25M
-10.57%323.25M
-5.33%329.53M
-3.48%364.04M
+4.08%358.33M
+13.53%361.45M
+22.14%348.09M
+42.28%377.16M
+32.15%344.29M
+37.81%318.37M
+37.57%285.01M
+39.22%265.08M
+23.24%260.54M
+7.11%231.02M
+1.04%207.17M
-21.87%190.41M
+0.97%211.40M
+5.11%215.68M
Total Other Finance Costs
-108.42%-2.03M
-291.42%-109.37M
+139.00%119.16M
+116.76%2.56M
-24.29%24.08M
+26.19%-27.94M
-14.59%49.86M
+69.92%-15.26M
-52.09%31.80M
-125.24%-37.86M
+142.85%58.38M
-184.34%-50.73M
+246.41%66.37M
+59.53%150.02M
-60.35%-136.25M
+52.82%60.15M
-144.35%-45.34M
+372.45%94.04M
-306.17%-84.97M
-39.42%39.36M
Special Income (Charges)
+102.02%429.40K
-153.45%-137.20M
+162.71%22.20M
-46.94%-69.65M
-110.38%-21.24M
+1178.45%256.71M
+83.71%-35.40M
+61.38%-47.40M
+61.33%-10.09M
+108.97%20.08M
-302.52%-217.36M
-37.03%-122.73M
-324.19%-26.11M
+65.31%-223.87M
+296.48%107.33M
+57.87%-89.56M
+8.16%-6.15M
-260.16%-645.40M
-95.37%-54.62M
-559.76%-212.58M
-Less:Impairment of Capital Assets
-139.00%-4.11M
+18.18%65.74M
-3.45%20.06M
+106.15%53.72M
+279.24%10.55M
+178.17%55.62M
-89.57%20.77M
-66.79%26.06M
-144.64%-5.89M
-139.78%-71.16M
+947.29%199.24M
+4.35%78.48M
+2158.02%13.18M
-69.34%178.90M
-51.17%19.02M
-62.41%75.21M
-108.85%-640.65K
+340.32%583.58M
+134.21%38.96M
+9362.96%200.09M
-Less:Other Special Charges
-490.77%-1.37M
+98.21%-6.59M
-3275.62%-60.65M
-772.50%-2.47M
+180.86%351.00K
-50174.96%-368.50M
+67.30%-1.80M
+78.45%-282.84K
-185.51%-434.10K
-94.93%735.90K
+96.03%-5.49M
+30.69%-1.31M
+173.65%507.68K
+78.03%14.50M
-1466.57%-138.40M
+3.45%-1.89M
+120.77%185.52K
+310.64%8.15M
+4721.27%10.13M
-121.63%-1.96M
-Less:Write Off
-51.08%5.06M
+38.97%78.05M
+11.94%18.39M
-14.92%18.40M
-37.03%10.34M
+11.56%56.17M
-30.41%16.43M
-52.54%21.62M
+32.24%16.41M
+65.26%50.34M
+95.99%23.61M
+180.38%45.56M
+87.81%12.41M
-43.24%30.46M
+117.46%12.04M
+12.46%16.25M
+1767.32%6.61M
+6.23%53.67M
-52.02%5.54M
-59.03%14.45M
Other Non-Operating Income (Expenses)
-58.80%-17.83M
-17.96%-46.95M
+29.63%-26.70M
-748.87%-31.50M
-281.92%-11.23M
-685.18%-39.80M
-67.86%-37.94M
-68.14%4.85M
+93.06%-2.94M
-93.67%6.80M
-54.17%-22.60M
+109.14%15.23M
-410.57%-42.38M
+147.36%107.44M
-54.22%-14.66M
-1709.78%-166.75M
+41.92%-8.30M
-1568.95%-226.85M
-1.50%-9.51M
-7373.62%-9.21M
Pretax Profit
+0.74%1.36B
+16.12%1.27B
-1.89%1.12B
+50.19%1.37B
+32.32%1.35B
+4036.07%1.10B
+79.02%1.14B
-28.17%912.78M
-26.46%1.02B
-102.32%-27.89M
-37.47%636.99M
-13.84%1.27B
+57.80%1.38B
-12.58%1.20B
-25.20%1.02B
-31.69%1.47B
-23.37%877.53M
+4.47%1.38B
+28.66%1.36B
+40.90%2.16B
Tax
-31.54%277.92M
-20.22%82.80M
-5.01%162.98M
+42.23%212.30M
+74.84%405.98M
+138.56%103.79M
+504.10%171.58M
-56.06%149.27M
-14.16%232.20M
-1850.21%-269.14M
-72.28%28.40M
+27.85%339.73M
+11.16%270.51M
-95.41%15.38M
-43.28%102.45M
-30.82%265.72M
+46.15%243.36M
+162.87%335.14M
-17.26%180.62M
+41.64%384.13M
Net Profit
+14.66%1.08B
+19.91%1.19B
-1.33%955.88M
+51.75%1.16B
+19.76%941.57M
+311.98%993.92M
+59.19%968.79M
-17.99%763.51M
-29.44%786.22M
-79.69%241.25M
-33.58%608.58M
-23.00%930.97M
+75.70%1.11B
+14.08%1.19B
-22.44%916.32M
-31.88%1.21B
-35.20%634.16M
-12.50%1.04B
+40.59%1.18B
+40.74%1.77B
Profit from Continuing Operations
+14.66%1.08B
+19.91%1.19B
-1.33%955.88M
+51.75%1.16B
+19.76%941.57M
+311.98%993.92M
+59.19%968.79M
-17.99%763.51M
-29.44%786.22M
-79.69%241.25M
-33.58%608.58M
-23.00%930.97M
+75.70%1.11B
+14.08%1.19B
-22.44%916.32M
-31.88%1.21B
-35.20%634.16M
-12.50%1.04B
+40.59%1.18B
+40.74%1.77B
Minority Interests
+18.10%208.80M
+46.83%344.57M
-26.45%134.56M
+49.17%221.43M
+0.18%176.81M
+69.99%234.68M
+77.63%182.94M
+5.68%148.45M
+38.66%176.49M
+229.41%138.05M
+550.58%102.99M
+8.13%140.47M
-28.33%127.28M
+13.02%-106.68M
-84.01%15.83M
-7.03%129.91M
+35.08%177.59M
-2059.71%-122.65M
+30.24%99.00M
+13.05%139.74M
Net Income to Parent Company
+13.87%870.83M
+11.59%847.27M
+4.52%821.33M
+52.38%937.21M
+25.42%764.76M
+635.70%759.24M
+55.43%785.84M
-22.19%615.06M
-38.22%609.73M
-92.03%103.20M
-43.85%505.59M
-26.75%790.50M
+116.17%986.97M
+11.22%1.29B
-16.80%900.48M
-34.00%1.08B
-46.11%456.57M
-1.68%1.16B
+41.62%1.08B
+43.75%1.64B
Other Preferred Stock Dividends
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Net Income to Common Stockholders
+13.87%870.83M
+11.59%847.27M
+4.52%821.33M
+52.38%937.21M
+25.42%764.76M
+635.70%759.24M
+55.43%785.84M
-22.19%615.06M
-38.22%609.73M
-92.03%103.20M
-43.85%505.59M
-26.75%790.50M
+116.17%986.97M
+11.22%1.29B
-16.80%900.48M
-34.00%1.08B
-46.11%456.57M
-1.68%1.16B
+41.62%1.08B
+43.75%1.64B
Basic EPS
+13.79%0.33
+10.34%0.32
+6.90%0.31
+52.17%0.35
+26.09%0.29
+866.67%0.29
+52.63%0.29
-23.33%0.23
-37.84%0.23
-93.88%0.03
-44.12%0.19
-28.57%0.30
+105.56%0.37
+6.52%0.49
-19.05%0.34
-34.38%0.42
-45.45%0.18
+0.00%0.46
+40.00%0.42
+45.45%0.64
Diluted EPS
+13.79%0.33
+10.34%0.32
+6.90%0.31
+52.17%0.35
+26.09%0.29
+866.67%0.29
+61.11%0.29
-23.33%0.23
-37.84%0.23
-93.88%0.03
-47.06%0.18
-28.57%0.30
+105.56%0.37
+6.52%0.49
-19.05%0.34
-34.38%0.42
-45.45%0.18
+0.00%0.46
+40.00%0.42
+45.45%0.64
Dividend Per Share
--0.00
--0.00
+14.91%0.32
--0.00
--0.00
--0.00
-33.64%0.28
--0.00
--0.00
--0.00
--0.42
-100.00%0.00
--0.00
--0.00
-100.00%0.00
--0.56
--0.00
--0.00
+11.13%0.43
--0.00
Deadline
Mar 31, 2026
Dec 31, 2025
Sep 30, 2025
Jun 30, 2025
Mar 31, 2025
Dec 31, 2024
Sep 30, 2024
Jun 30, 2024
Mar 31, 2024
Dec 31, 2023
Sep 30, 2023
Jun 30, 2023
Mar 31, 2023
Dec 31, 2022
Sep 30, 2022
Jun 30, 2022
Mar 31, 2022
Dec 31, 2021
Sep 30, 2021
Jun 30, 2021
Accounting Standard
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
2026/Q12025/Q42025/Q32025/Q22025/Q12024/Q42024/Q32024/Q22024/Q12023/Q42023/Q32023/Q22023/Q12022/Q42022/Q32022/Q22022/Q12021/Q42021/Q32021/Q2
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On August 24 (U.S. Eastern Time), U.S. Treasury Secretary Bessent announced "unprecedented" economic actions against Iran, aiming to sever i Show More